Hypertension and diabetes are affected by the use of calcineurin inhibitors (CNI) and corticosteroids (STR), while dyslipidemia is affected by the use of CNI, STR, and mammalian target of rapamycin (mTOR) inhibitor (Elezaby et al., 2022). The gene discussed is MTOR; the disease is hypertensive disorder.